As psoriasis maintenance therapy, step-down matched full-dose etanercept for quality of life measuresAugust 22, 2015SpondyloarthropathiesPsoriatic Arthritis
New era ahead in spondyloarthritis therapyAugust 21, 2015Psoriatic ArthritisSpondyloarthropathiesAnkylosing spondylitis
Biologic treatment for psoriasis found to have CVD benefitsAugust 19, 2015SpondyloarthropathiesPsoriatic Arthritis
Strong evidence for tuberculosis screening before psoriasis, PsA biologic therapyAugust 13, 2015Psoriatic ArthritisSpondyloarthropathies
Reciprocal risks found between psoriatic disease and uveitisAugust 13, 2015Psoriatic ArthritisSpondyloarthropathies
PsA disease activity and treatment success definedAugust 13, 2015Psoriatic ArthritisSpondyloarthropathies
GRAPPA initiatives continue to chart the way for psoriasis, psoriatic arthritisJuly 22, 2015Psoriatic ArthritisSpondyloarthropathies
Secukinumab proves successful against psoriatic arthritis in FUTURE 2 trialJuly 17, 2015Psoriatic ArthritisSpondyloarthropathies
WCD: Touch avoidance is a new dimension of psoriatic impairmentJuly 13, 2015Psoriatic ArthritisSpondyloarthropathies
EULAR’s psoriatic arthritis recommendations gain new drugsJuly 1, 2015Psoriatic ArthritisSpondyloarthropathies
EULAR: Panel targets six rheumatic disease comorbiditiesJuly 1, 2015Rheumatoid ArthritisPsoriatic ArthritisGoutLupus & Connective Tissue DiseasesSpondyloarthropathies
WCD: Secukinumab shows effectiveness for nail, palmoplantar psoriasisJune 28, 2015SpondyloarthropathiesPsoriatic Arthritis
WCD: IL-23p19 inhibitors yield ‘promising’ psoriasis resultsJune 28, 2015Psoriatic ArthritisSpondyloarthropathies
